Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows
International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1843
DOI: 10.3390/ijms25031843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Julia Martín-Vírgala und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Ovied…. Hauptthemen laut MEDLINE: Chronic Kidney Disease-Mineral and Bone Disorder, Healthy Aging, Klotho Proteins. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Plan Estatal de I+D+I 2013-2016, Plan de Ciencia, Tecnología e Innovación 2013-2017 y 2018-2022 del Principado de Asturias, Fundación Renal Iñigo Álvarez de Toledo (FRIAT).
Abstract (Originalsprache)
Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a biomarker in CKD. αKlotho is synthesized mainly in the kidneys, but it can be released into the bloodstream and urine as soluble Klotho (sKlotho), which undertakes systemic actions, independently or in combination with FGF23. It is usually accepted that sKlotho levels are reduced early in CKD and that lower levels of sKlotho might be associated with the main chronic kidney disease–mineral bone disorders (CKD-MBDs): cardiovascular and bone disease. However, as results are inconsistent, the applicability of sKlotho as a CKD-MBD biomarker is still a matter of controversy. Much of the inconsistency can be explained due to low sample numbers, the low quality of clinical studies, the lack of standardized assays to assess sKlotho and a lack of consensus on sample processing, especially in urine. In recent decades, because of our longer life expectancies, the prevalence of accelerated-ageing diseases, such as CKD, has increased. Exercise, social interaction and caloric restriction are considered key factors for healthy ageing. While exercise and social interaction seem to be related to higher serum sKlotho levels, it is not clear whether serum sKlotho might be influenced by caloric restriction. This review focuses on the possible role of sKlotho as a biomarker in CKD-MBD, highlighting the difference between solid knowledge and areas requiring further research, including the role of sKlotho in healthy ageing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS2040, Kidney Disease), 28040 Madrid, Spain.
- Área 5-Fisiología y Fisiopatología Renal y Vascular del Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Physiology Unit, Department of Systems Biology, Facultad de Medicina y Ciencias de la Salud, Universid…
- Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
- Nephrology Unit, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
- Department of Medicine, Universidad de Oviedo, 33011 Oviedo, Spain.
ORCID-Profile: Beatriz Martín-Carro, José Luis Fernández-Martín, Cristina Alonso-Montes, Natalia Carrillo-López
Förderung
- Instituto de Salud Carlos III
- Plan Estatal de I+D+I 2013-2016, Plan de Ciencia, Tecnología e Innovación 2013-2017 y 2018-2022 del Principado de Asturias
- Fundación Renal Iñigo Álvarez de Toledo (FRIAT)
- European Union
- ISCIII Retic REDinREN
- ISCIII Red de Investigación Cooperativa Orientada a Resultados en Salud RICORS2040
- Plan Estatal de I+D+I 2013–2016, Plan de Ciencia, Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Martín-Vírgala, J., Martín-Carro, B., Fernández-Villabrille, S., Ruiz-Torres, M. P., Gómez-Alonso, C., Rodríguez-García, M., Fernández-Martín, J. L., Alonso-Montes, C., Panizo, S., Cannata-Andía, J. B., Naves-Díaz, M., & Carrillo-López, N. (2024). Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows. International Journal of Molecular Sciences, 25(3), 1843. https://doi.org/10.3390/ijms25031843
Vancouver
Martín-Vírgala J, Martín-Carro B, Fernández-Villabrille S, Ruiz-Torres MP, Gómez-Alonso C, Rodríguez-García M, et al. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows. International Journal of Molecular Sciences. 2024;25(3):1843. doi:10.3390/ijms25031843
BibTeX
@article{MartnVrgala2024,
author = {Martín-Vírgala, Julia and Martín-Carro, Beatriz and Fernández-Villabrille, Sara and Ruiz-Torres, María Piedad and Gómez-Alonso, Carlos and Rodríguez-García, Minerva and Fernández-Martín, José Luis and Alonso-Montes, Cristina and Panizo, Sara and Cannata-Andía, Jorge B and Naves-Díaz, Manuel and Carrillo-López, Natalia},
title = {Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1843},
doi = {10.3390/ijms25031843}
}
EUVIMED